Androgen News and Research

RSS
Researchers provide evidence supporting need for gender-specific anti-inflammatory drugs

Researchers provide evidence supporting need for gender-specific anti-inflammatory drugs

Excess male hormones in PCOS women contribute to metabolic complications, study shows

Excess male hormones in PCOS women contribute to metabolic complications, study shows

Moffitt researchers develop novel drug that may help combat castration-resistant prostate cancer

Moffitt researchers develop novel drug that may help combat castration-resistant prostate cancer

Study explores effects of androgen deprivation therapy on overall geriatric health

Study explores effects of androgen deprivation therapy on overall geriatric health

Standard therapy plus abiraterone lowers relative risk of death in men with advanced prostate cancer

Standard therapy plus abiraterone lowers relative risk of death in men with advanced prostate cancer

AMSBIO introduces new Reporter Lentivirus for assessing cell signaling activities

AMSBIO introduces new Reporter Lentivirus for assessing cell signaling activities

Precise delivery of HDR brachytherapy provides good quality of life to prostate cancer patients

Precise delivery of HDR brachytherapy provides good quality of life to prostate cancer patients

Molecular mechanism reprograms tumor cells to drive treatment resistance in advanced prostate cancer

Molecular mechanism reprograms tumor cells to drive treatment resistance in advanced prostate cancer

Combined treatment regimen shows early promise in eliminating metastatic prostate cancer

Combined treatment regimen shows early promise in eliminating metastatic prostate cancer

Clinical study examines impact of yoga on side-effects caused by prostate cancer treatment

Clinical study examines impact of yoga on side-effects caused by prostate cancer treatment

Treating PCOS in adolescent girls may help prevent future subfertility, research suggests

Treating PCOS in adolescent girls may help prevent future subfertility, research suggests

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Novel highly potent SARDs may offer treatment option for advanced prostate cancer, study reports

Novel highly potent SARDs may offer treatment option for advanced prostate cancer, study reports

QIAGEN announces commercialization of AdnaTest kit for clinical research in prostate cancer

QIAGEN announces commercialization of AdnaTest kit for clinical research in prostate cancer

New analysis shows correlation between testosterone-lowering therapy for prostate cancer and dementia

New analysis shows correlation between testosterone-lowering therapy for prostate cancer and dementia

Androgens more important for ovarian development, study suggests

Androgens more important for ovarian development, study suggests

Direct-to-consumer ‘low-T’ medication advertising increases prescriptions but may not improve health

Direct-to-consumer ‘low-T’ medication advertising increases prescriptions but may not improve health

Novel androgens play major role in development of PCOS, research shows

Novel androgens play major role in development of PCOS, research shows

Mayo study provides vital information on tumor sequencing in newly diagnosed breast cancer patients

Mayo study provides vital information on tumor sequencing in newly diagnosed breast cancer patients

Endostatin can decrease proliferation of castration-resistant prostate cancer cells

Endostatin can decrease proliferation of castration-resistant prostate cancer cells